Novartis Investigative Site — Rochester, New York

Novartis Investigative Site is a clinical research site located in Rochester, New York, United States 14618-2638.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 44 clinical trials.

Therapeutic areas: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Diabetic Macular Edema.

Sponsors: Novartis Pharmaceuticals, Novartis.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 44 clinical trials on record. Their work covers Asthma, Chronic Obstructive Pulmonary Disease (COPD), Diabetic Macular Edema.

Is Novartis Investigative Site accredited by Crixeo Health?

Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.